Dietary Considerations
Nausea leads the list, and some people also get vomiting, diarrhea, constipation, or stomach discomfort
Semaglutide should be avoided if Individuals suffering from pre-existing health conditions such as pancreatitis, decreased kidney function, low blood sugar, multiple endocrine neoplasia type 2, gallbladder disease, and diabetic retinopathy
Medicare or Medicaid Medicare and Medicaid might cover semaglutide for people with type 2 diabetes
doi:10.1016/0006-2952(93)90360-9
On average, clinical trials have found that patients on semaglutide (the active ingredient in Ozempic and Wegovy) may lose between 15% to 20% of their body weight within the first year of use